
October 1, 2026
UNC Health Advances Gene Therapy Research for Rett Syndrome
A clinical trial at UNC Hospitals offers new hope for children and families affected by the rare neurological disorder.

October 1, 2026
A clinical trial at UNC Hospitals offers new hope for children and families affected by the rare neurological disorder.

September 25, 2026
Researchers hope to create a therapy that reduces the fear, anxiety and lifestyle limitations associated with peanut allergy.

August 3, 2026
Researchers are investigating a new way to tackle bone cancer while minimizing toxicity typically associated with chemotherapy.

May 11, 2026
A new international perspective led by UNC School of Medicine researchers highlights that oral food challenges, historically considered essential to food allergy clinical trials, are now limiting who can participate and threatening to slow progress in food allergy research.

March 23, 2026
With a medical degree and a master’s in business administration, Scott Giberson aims to transform healthcare systems while making a meaningful difference for children and their families.

March 5, 2026
In a new paper, researchers propose treating health data as essential national infrastructure, balancing patient empowerment, privacy, innovation, and public good.

February 26, 2026
A geneticist at the UNC School of Medicine has coordinated the development of Mondo, the world’s first standardized rare disease coding tool. Mondo is designed to streamline the diagnosis and treatment planning for millions of patients with rare diseases internationally.

December 18, 2025
This project is co-led by Dual Principal Investigators Dr. Kori Flower at the University of North Carolina at Chapel Hill and Dr. Eliana Perrin at The Johns Hopkins University.

December 9, 2025
A clinical trial led by the UNC School of Medicine weighs medications versus ‘wait and see’ approach for treatment of patent ductus arteriosus.

November 11, 2025
The society recognizes distinguished academic leaders, educators, and researchers whose contributions have earned national and international acclaim.

October 21, 2025
The Pediatric Infectious Diseases Society (PIDS) has named Dr. Matthew Vogt, Assistant Professor of Pediatrics (Infectious Diseases) and Microbiology & Immunology at the University of North Carolina at Chapel Hill, the recipient of its prestigious 2025 Young Investigator Award.

September 23, 2025
Experts at the UNC School of Medicine played a pivotal role in the approval of a new medication for pediatric patients that could also be used to treat other types of cancer.